Through gene therapy, researchers engineered blood-forming stem cells (hematopoietic stem/progenitor cells, or HSPCs) to carry chimeric antigen receptor (CAR) genes to make cells that can detect and destroy HIV-infected cells. These engineered cells not only destroyed the infected cells, they persisted for more than two years, suggesting the potential to create long-term immunity from the virus that causes AIDS.
Antiviral drugs can suppress the amount of HIV in the body to nearly undetectable levels, but only an effective immune response can eradicate the virus. Researchers have been seeking a way to improve the body’s ability to combat the virus by engineering blood-forming stem cells to specifically target and kill HIV-infected cells for the life of the individual. Although chimeric antigen receptor (CAR) T-cells have emerged as a powerful immunotherapy for various forms of cancer – and show promise in treating HIV-1 infection – the therapy may not impart long-lasting immunity. Researchers, physicians and patients need T cell-based products that can respond to malignant or infected cells that may reappear months or years after treatment.
Because HIV uses CD4 to infect cells, the researchers used a CAR molecule that hijacks the essential interaction between HIV and the cell surface molecule CD4 to make stem cell-derived T-cells target infected cells. When the CD4 on the CAR molecule binds to HIV, other regions of the CAR molecule signal the cell to become activated and kill the HIV infected cell. The researchers found that, in test animals, modification of the blood-forming stem cells resulted in more than two years of stable production of CAR-expressing cells without any adverse effects. In addition, these cells were widely distributed throughout the lymphoid tissues and gastrointestinal tract, which are major anatomic sites for HIV replication and persistence in infected people. Most important, engineered CAR T-cells showed efficacy in attacking and killing HIV-infected cells.
These findings are the first to show that blood-forming stem cells can be modified with a CAR therapy that can safely engraft in the bone marrow, mature and become functional immune cells throughout the body. This could lead to the development of an approach allowing for safe, lifelong immunity to HIV. Such an approach is likely to work best when performed in combination with other treatment strategies, such as antiretroviral therapy. Researchers hope that this type of therapy could reduce infected individuals’ dependence on antiviral medications, lower the cost of therapy, and permit the possible eradication of HIV from its hiding places in the body. The approach also has potential against other infections or malignancies.
The Latest on: HIV gene therapy
- HIV used in gene therapy to fix ‘bubble boy’ diseaseon November 16, 2019 at 4:00 pm
Now eight babies with “bubble boy disease” have had it fixed by a gene therapy made from one of the immune system’s worst enemies — HIV, the virus that causes AIDS. A study out Wednesday details how ...
- A grandpa's hope for hemophilia cure leads him to gene therapy clinical trialon November 15, 2019 at 4:00 pm
Contaminated blood used for treatment decades ago left Addie with HIV, not uncommon among those his age with ... Addie is in a clinical trial of a gene therapy for hemophilia developed by biotech ...
- HIV Gene Therapy — Self Experimental Protocol (N6 v2)on November 11, 2019 at 8:47 pm
Summary: In late 2017, I tested out a gene therapy that targets HIV. The describes the protocol used for testing out a similar yet different gene vector, as well as an update following the first week.
- Physician Goes Behind The Scenes To Write Compelling Story About Treating Patients With New Cancer Gene Therapyon November 4, 2019 at 6:15 am
The Washington Post: Science Author Digs Into The Story About A Revolutionary Cancer Treatment Used In Immunotherapy In 2017, CAR-T therapy ... of HIV infection. The study focused on people who carry ...
- Gene Therapy Using CAR T-Cells Could Provide Long-Term Protection Against HIVon November 2, 2019 at 5:00 pm
Through gene therapy, researchers engineered blood-forming stem cells (hematopoietic stem/progenitor cells, or HSPCs) to carry chimeric antigen receptor (CAR) genes to make cells that can detect and ...
- CRISPR is Editing its Way Toward Cell and Gene Therapyon October 31, 2019 at 8:51 am
A phrase that perfectly encapsulates the therapeutic potential of gene editing and encompasses how investigators ... primary human CD4 + T cells to analyze the role of host factors in HIV replication ...
- Gates Foundation, NIH Bet on Gene Therapy To Bring Cheap HIV and Sickle Cell Cures to Sub-Saharan Africaon October 25, 2019 at 1:03 pm
"There have been several attempts to use gene therapy for HIV by either incorporating genes that suppress HIV genes, producing decoys for various viruses required processes needed for viral ...
- GeoVax up 54% on planned study of HIV gene therapy/vaccine comboon October 24, 2019 at 9:03 am
The company has agreed to supply its MVA-VLP HIV vaccine (MVA62B) for use in one arm of a planned Phase 1 study that will assess the product, combined with American's gene therapy AGT103-T, in ...
- Can Gene Therapy Cure HIV? US Gov't. Is Banking $100 Million On It.on October 23, 2019 at 11:10 am
Although current treatments with antiretroviral therapy (ART) are effective at suppressing ... Although scientists are working to develop gene-based cures for HIV, these approaches are often costly ...
- Gene Therapy Market In-Depth Analysis 2019 :: Leading Key Players, Size, Shareon October 3, 2019 at 11:13 pm
Gene therapy is a widely used technique for the study by researchers in order to develop treatment of various diseases such as HIV, Cancer, Parkinson’s disease, hemophilia and even immune deficiencies ...
via Google News and Bing News